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The cases of 90 homosexual or bisexual men with 
generalized lymphadenopathy were studied by 
epidemiologic, clinical, pathologic, immunologic, and 
genetic methods. The patients ranged in age from 20 to 
52 years and had histories of multiple sexually 
transmitted diseases and both recreational and 
prescription drug use. Histologically, their lymph nodes 
showed three patterns: explosive follicular hyperplasia; 
follicular involution with expansion of the paracortical 
area; and a mixed pattern of follicular hyperplasia and 
follicular involution in the same lymph node. The 
frequency of HLA-DR5 was significantly increased in these 
patients (p < 0.005) compared with that in controls. All 
patients had impaired cell-mediated immunity. 
Opportunistic infections, lymphomas, or Kaposi's sarcoma 
subsequently developed in 15 patients who had had 
severe immune dysfunction for the previous 3 to 13 
months. We suggest that generalized lymphadenopathy is 
part of the spectrum of a disorder manifested by acquired 
immunodeficiency, opportunistic infections, Kaposi's 
sarcoma, and malignant lymphomas. 
S I N C E 1981, an outbreak of acquired immune dysfunc-
tion manifest by opportunistic infections (1-4) and neo-
plastic disorders such as Kaposi's sarcoma (5) and ma-
lignant lymphomas (6, 7) has been reported in more than 
1000 homosexual men. Recently, an increased incidence 
of generalized lymphadenopathy has been seen in previ-
ously healthy homosexual men in large cities (8) . The 
patients are characterized as having lymphadenopathy of 
at least 3 months' duration that involves two or more 
extrainguinal sites, absence of any current illness or drugs 
known to cause lymphadenopathy, and the presence of 
reactive hyperplasia in lymph node biopsy samples. Our 
study was done after we recognized that generalized lym-
phadenopathy preceded opportunistic infections and the 
skin lesions of Kaposi's sarcoma in some patients. The 
phenomenon of generalized lymphadenopathy also al-
lowed us to follow these patients prospectively to deter-
mine the natural course of this disorder and correlate this 
course with alterations in immune function and HLA 
phenotypes. 
We report the findings of our clinical, epidemiologic, 
immunologic, histologic, and genetic studies on 90 previ-
ously undescribed cases of generalized lymphadenopathy. 
All patients were homosexual men, evaluated prospec-
tively at The New York Hospital between 1 November 
1981 and 1 July 1983. Each patient was found to have a 
similar immunologic defect indicative of a T-cell dysfunc-
tion. We propose that generalized lymphadenopathy is 
part of the spectrum of a disorder manifested by acquired 
immunodeficiency, opportunistic infections, Kaposi's sar-
coma, and, in some cases, malignant lymphomas. 
Materials and Methods 
All 90 patients were homosexual or bisexual men referred to 
The New York Hospital for evaluation of generalized lympha-
denopathy. For this study, generalized lymphadenopathy was 
denned as lymphadenopathy involving two or more extraingui-
nal sites ( > 1.0 cm in diameter) of at least 3 months' duration 
in the absence of any current illness or drugs known to cause 
lymphadenopathy. The patients were examined at intervals of 4 
months or less for 8 to 19 months. Patients who simultaneously 
had the following conditions were excluded from the study: 
cutaneous or lymphadenopathic forms of Kaposi's sarcoma; op-
portunistic infections; or the prodromal syndrome character-
ized by the combination of generalized lymphadenopathy, fever, 
diarrhea, weight loss, sweating, and nightsweats. 
Complement-fixing antibody titers for cytomegalovirus and 
herpes simplex virus were determined for patient's sera, as pre-
viously described (9, 10). Levels of serum antibodies to Ep-
stein-Barr viral capsid antigens were measured by the indirect 
immunofluorescent technique. Ten-well microscope slides con-
taining the acetone-fixed, Epstein-Barr viral capsid antigen-pos-
itive, T 3 HR IK Burkitt's lymphoma cell line (Litton Bionet-
ics, Inc., Kensington, Maryland) were used (11, 12). Levels of 
hepatitis B surface antigen, hepatitis B IgG antibody, and hepa-
titis A IgG antibody were measured by radioimmunoassay (13, 
14). Pneumocystis carinii pneumonia was diagnosed by methe-
namine silver staining of lung biopsy tissue, and Cryptosporidi-
um was diagnosed from small bowel biopsy specimens. 
Natural killer cell activity was assessed by a short-term 51Cr 
release assay with freshly isolated peripheral blood mononu-
clear cells against the human target cell K562, as previously 
described (15). In brief, 51Cr-labeled target cells were incubat-
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Muscle pain 31(34) 
Painful adenopathy 20(22) 
Skin rash 20(22) 
Recurrent viral-like illnesses 13(14) 
Nightsweats 12(13) 
Sweating 11(12) 
Decreased libido 7 (8) 
Sinusitis 7 (8) 
Diffuse alopecia 4 (4) 
Dyspnea 4 (4) 
Arthralgias 3 (3) 
Diarrhea 3 (3) 
ed at lymphocyte:target ratios of 100:1, 50:1, and 25:1 in round-
bottomed well microplates for 4 hours at 37° C in humidified 
5% CO2 in air. Plates were then centrifuged, and the amount of 
radioactivity released in the supernatants was measured. The 
percentage of cytotoxicity was calculated according to the for-
mula: Percent cytotoxicity = (release in test — spontaneous 
release)/(total release — spontaneous release). Mean values 
were obtained for statistical evaluation from each triplicate de-
termination. 
T-cell function was assessed in vivo by delayed cutaneous 
reactivity after intradermal administration of Candida, mumps, 
Trichophyton, and tuberculin. Lymphocyte transformation was 
assessed by incorporation of 14C-thymidine in response to stim-
ulation with mitogens, as previously described (16). The mito-
gens used and the final concentrations were as follows: phyto-
hemagglutinin at 175, 143, 71, 47, 24, 12, 5, and 3 jug/mL; and 
pokeweed mitogen at 142, 71, 14, and 3 /ng/mL. Microbial 
activators were prepared and used as previously described (17, 
18). Results of lymphocyte proliferation studies were expressed 
as the net counts per minute (lymphocytes in a stimulated cul-
ture minus lymphocytes in an unstimulated culture). There was 
no difference in background counts between patients and con-
trols. 
The patients were HLA-typed for the well characterized anti-
gens of the HLA-A, -B, and -C loci by the standard two-stage 
microcytotoxicity test using a large battery of established anti-
sera. The patients were also typed for the B-cell alloantigens 
DR1 to DRwlO, using B lymphocytes isolated after elimination 
of T cell, passed through a nylon column (19), and using high-
ly selected reagents. Test results for white patients were com-
pared with those obtained from 176 persons who were typed for 
the HLA-DR locus antigens and 388 persons who were typed 
for the HLA-A, -B, and -C antigens. The controls were healthy 
white persons of the metropolitan New York City area having 
approximately the same geographical backgrounds as the white 
patients in our study. 
Results 
PATIENT POPULATION 
Patients were referred to The New York Hospital for 
evaluation of generalized lymphadenopathy. The 90 pa-
tients were all men, 20 to 52 years old (mean age, 32.3 
years). Eighty-four patients described themselves as ho-
mosexual, and 6, as bisexual. Two patients were married. 
Six patients were black; 6, Hispanic; and 78, white. For-
ty-seven patients knew persons with acquired immunode-
ficiency, and 39 patients were aware of having had sexual 
contacts within the past 2 years with men who subse-
quently developed Kaposi's sarcoma, opportunistic infec-
tions, malignant lymphomas, or generalized lymphadeno-
pathy. None of the patients had a personal or family his-
tory of unusual, severe, or recurrent infections before the 
onset of symptoms. All but 2 patients reported the occa-
sional or regular use of various recreational drugs, in-
cluding marijuana in 86, nitrites (amyl, butyl, or both) in 
86, cocaine in 69, LSD in 51, amphetamines in 46, 
methaqualone in 45, mescaline in 44, methylenedioxy-
amphetamine in 19, tetrahydrocannabinol in 17, phency-
clidine in 15, Tuinal (Eli Lilly & Co., Indianapolis, Indi-
ana; combination product of amobarbital sodium and 
secobarbital sodium) in 14, opium in 8, and heroin in 3. 
All patients had had one or more sexually transmitted 
diseases in the past, including gonorrhea in 75, hepatitis 
B in 67, amebiasis in 55, hepatitis A in 54, condyloma 
acuminata in 40, syphilis in 22, herpes simplex progeni-
talis in 17, Giardia lamblia in 16, and lymphogranuloma 
venereum in 1. No single venereal disease or treatment 
was common to all patients. 
CLINICAL ILLNESS 
Twenty-three patients noted a viral-like illness that 
was characterized by sore throat, low-grade fever, myal-
gias, and fatigue just before the onset of lymphadeno 
pathy (Table 1). The duration of the lymphadenopathy 
before the study varied among patients; most patients 
had had lymphadenopathy for more than 6 months. The 
longest duration was 56 months. 
The commonest symptom at presentation was easy fa-
tigability. This fatigue was usually mild, but in several 
cases it was severe enough to interfere with routine activi-
ties. Recurrent viral-like illnesses occurred in 13 patients, 
and 20 patients had painful adenopathy, especially in the 
axillae. 
On initial physical examination, all patients had in-
volvement of the cervical, axillary, and occipital lymph 
nodes. Other lymph nodes involved included the subman-
dibular in 8 and submental in 5. The lymph nodes were 
usually discrete but occassionally were matted together 
and tender. The size of the individual lymph nodes tend-
ed to fluctuate and ranged from 0.5 to 5.0 cm in diame-
ter. Splenomegaly was present in 18 patients, with the 
spleen extending 1 to 6 cm below the left costal margin. 
In 3 patients splenomegaly was intermittent. Dermato-
logic problems included dermatitis or eczema that re-
sponded poorly to topical steroids for the duration of the 
lymphadenopathy, in 9 patients; tinea versicolor in 9; and 
recurrent episodes of staphylococcal impetigo in 2. Burn-
ing in both lower extremities with normal sensory and 
motor examinations and normal nerve conduction studies 
was present in 1 patient. 
LABORATORY EVALUATION 
At initial presentation, 14 patients had mild anemia 
(hematocrit, 3 1 % to 3 9 % ) . Leukopenia (1060 to 3000 
leukocytes/mm3) was seen in 3 patients, and lymphope-
nia in 2 patients. Thrombocytopenia (platelet count, less 
than 100 000/mm 3 ) was seen in 6 patients. Thirteen pa-
tients presenting with these hematologic abnormalities 
had bone marrow examinations. All bone marrow aspi-
rates showed a relative increase in the number of mature 
5 8 6 November 1983 • Annals of Internal Medicine • Volume 99 • Number 5 
Downloaded From: http://annals.org/ by a Penn State University Hershey User  on 10/06/2016
lymphocytes, plasma cells, and eosinophils. Four basic 
patterns were seen: a hyperplastic bone marrow indicat-
ing either peripheral destruction or sequestration of ma-
ture cellular elements, in 9 patients; severe bone marrow 
hypoplasia, in 1 patient; marked left shift in the myeloid 
series, in 1 patient; and infiltration with lymphoblasts in-
dicating a lymphoproliferative disorder, in 2 patients. 
An additional laboratory abnormality was elevation of 
the serum globulin level in 28 patients. Immunoelectro-
phoresis showed polyclonal elevations in IgG (724 to 
4200 mg/dL; normal, 616 to 1647 m g / d L ) , IgA (62 to 
610 mg/dL; normal, 59 to 371 m g / d L ) , and IgM (61 to 
510 mg/dL; normal, 57 to 343 m g / d L ) . Mild elevations 
in levels of both aspartate transaminase (58 to 165 I U / 
dL; normal, up to 40 I U / d L ) and alanine transaminase 
(60 to 180 IU/dL; normal, up to 40 I U / d L ) were found 
in 10 patients who were hepatitis-B-surface-antigen-nega-
tive and in the absence of IgM antibody to hepatitis A. 
All patients had antibody to the viral capsid antigen of 
Epstein-Barr virus (1:40 to 1:2560). However, none had 
a positive heterophile antibody. Eighty-four patients had 
antibody to cytomegalovirus (1:8 to 1: > 512), and 85 
patients, to herpes simplex virus (1:8 to 1:32). The sera 
of 5 patients were anticomplementary in the assay for 
complement-fixing antibody to cytomegalovirus and her-
pes simplex virus. 
HISTOPATHOLOGIC FEATURES OF LYMPH NODES 
Lymph node biopsies were done on 77 patients at ini-
tial presentation. The biopsy sites were the cervical 
lymph nodes in 56, axillary in 18, and submental in 3. 
The biopsy results in 73 patients were characterized by 
marked and explosive follicular hyperplasia involving 
both the cortex and medullary zones (Figure 1A). The 
follicles were generally round or oval, but in some cases 
the follicles tended to become confluent and assumed ser-
pentine, hourglass, or irregular shapes with focal disrup-
tions of the mantle zone. These changes were present 
even in lymph nodes that were normal in size. 
The cellular composition within the center of the folli-
cles varied. In some cases, the constituents of the follicu-
lar centers were heterogeneous, consisting of an admix-
ture of small cleaved cells, large cleaved cells, rare plas-
ma cells, and immunoblasts. With greater expansion of 
the follicles, there was an increase in the proportion of 
large cleaved cells, large noncleaved cells, and immuno-
blasts within the follicles (Figure IB) . Mitotic activity 
within the follicles was high. 
In four patients the biopsy results were characterized 
by follicular involution with small, hypocellular, some-
times hyalinized follicles and paracortical hyperplasia 
(Figure 1C). Vascular proliferation was prominent in the 
interfollicular areas. The medullary cords were frequent-
ly packed with sheets of plasma cells. 
IMMUNOLOGIC AND HISTOCOMPATIBILITY TESTS 
Immunologic studies were done on all patients at ini-
tial presentation. Only five patients had cutaneous reac-
tivity to intradermal testing with antigens that included 
purified protein derivative of tuberculosis, mumps, Can-
Figure 1A. A low-power photomicrograph of a lymph node showing 
marked follicular hyperplasia and a prominent mantle zone. Arrow 
shows an area of attenuation of the mantle zone. (Hematoxylin and 
eosin; original magnification, x 12.8.) B. A high-power photomi-
crograph of a reactive follicle center illustrating the predominance 
of large noncleaved cells and immunoblasts. (Hematoxylin and eo-
sin; original magnification, x 80.) C. A low-power photomicrograph 
of a lymph node showing the striking expansion of the parafollicular 
area and the involution of follicles which appear very small in size. 
Arrows show inactive or involuted follicles. (Hematoxylin and eosin; 
original magnification, x 12.8.) 
dida, and Trichophyton. 
Forty-three of ninety patients (47.8%) had natural 
killer cell activity at a level less than 14.7% of the specific 
release at an effectontarget ratio of 100:1 (Figure 2) . 
This level of activity was previously found to be negative 
(15). The same magnitude of difference was observed 
between patients and controls at the other effector:target 
ratios. None of the controls had negative natural killer 
cell activity. Attempts to augment natural killer cell ac-
Metroka et al. • Lymphadenopathy in Homosexuals 587 
Downloaded From: http://annals.org/ by a Penn State University Hershey User  on 10/06/2016
Figure 2. Natural killer cell activity in vitro of freshly isolated pe-
ripheral blood mononuclear cells against the human target cell line 
K562 of patients with generalized lymphadenopathy and healthy 
controls. The response is at an effector:target cell ratio of 1 0 0 : 1 . 
tivity in ten patients with 800 units of recombinant alpha-
interferon in vitro did not lead to a significant increase in 
activity, indicating that the precursor pool was reduced, 
absent, or unresponsive to the interferon. 
An impaired cellular immune response was seen in all 
patients, as compared with controls, in in-vitro studies of 
T-lymphocyte activation using phytohemagglutinin and 
the T-cell-dependent B-lymphocyte activators, pokeweed 
mitogen, Candida albicans, Escherichia coli, and Staphy-
lococcus aureus (Figure 3). The response reflects the 
maximal lymphocyte proliferation rate that could be elic-
ited within a range of concentrations of lymphocyte acti-
vators. The maximum lymphoproliferative response to 
the mitogens were as follows: phytohemagglutinin, 24 to 
71 u.g/mL; pokeweed mitogen, 14 to 71 u.g/mL; and C. 
albicans, E. coli, and S. aureus, at dilutions of 1:20 to 
1:100. There was no difference in the slopes of the con-
centration curves between the patients and controls. Be-
cause all studies were done with pooled normal serum, 
serum factors could not have contributed to the deficient 
response seen. 
Typing of HLA-A, -B, -C, and -DR was done success-
fully in 72 white patients. Twenty-nine (40.3%) of these 
patients were found to have HLA-DR5 antigen, a rate 
that was significantly higher than that in the control 
group (20%) (X2 = 9.38; p < 0.005). The frequencies 
of other H L A determinants were not significantly differ-
ent between patients and controls. 
CLINICAL COURSE 
All 90 patients were followed prospectively at intervals 
of 4 months or less. The median follow-up period was 14 
months, with a range of 8 to 19 months. None of the 
patients were treated with any drugs other than those 
required for infectious complications. Complete regres-
sion of the lymph nodes was seen in 4 patients. Oppor-
tunistic infections developed in 3 of these patients 6 to 11 
months after lymph node regression, suggesting that sig-
nificant lymph node regression may occur in some pa-
tients before the development of an opportunistic infec-
tion. 
Life-threatening opportunistic infections or malignan-
cies developed in 15 patients (Table 2) ; 10 of these pa-
tients developed a wasting syndrome characterized by ex-
treme fatigue, sweating, nightsweats, fever, and weight 
loss after the onset of lymphadenopathy but before op-
portunistic infections or lymphomas were diagnosed. Ad-
ditional non-life-threatening complications occurred in 
Figure 3. Maximum proliferation of lymphocytes from patients with generalized lymphadenopathy and from healthy controls. A. Response to 
phytohemagglutinin (PHA). B. Response to pokeweed mitogen {PWM). C. Response to the microbial activators Candida albicans, Escherichia 
coli, and Staphylococcus aureus. CPM = counts per minute; P = patient; C = control. 
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Table 2. Clinical Features and Complications of Patients with Generalized Lymphadenopathy 












2 47 56 Follicular 
hyperplasia 
+ — Immunoblastic sarcoma, P. 
carinii pneumonia 
Died 
3 27 8 Follicular 
hyperplasia 




4 29 11 Not done 4- — Autoimmune 
thrombocytopenic 





5 30 16 Follicular 
hyperplasia 
— + Polymorphic lymphoma Died 
6 31 4 Follicular 
hyperplasia 
— + P. carinii pneumonia, 




7 44 16 Follicular 
involution 
— + Mixed cellular lymphoma Alive 










10 34 44 Follicular 
hyperplasia 
— — P. carinii pneumonia Died 
11 52 28 Follicular 
hyperplasia 
+ + Polymorphic lymphoma Alive 
12 38 31 Not done Not done Oral candidiasis, P. carinii 
pneumonia 
Died 
13 40 39 Follicular 
hyperplasia 






14 31 54 Not done + P. carinii pneumonia Alive 




* -+ = positive; — = negative. 
11 other patients and included oral candidiasis in 3; re-
current herpes zoster in 3; autoimmune thrombocytope-
nic purpura in 1; transient, painless, seventh nerve palsy 
in 1; recurrent staphylococcal abscesses requiring drain-
age and intravenous antibiotic therapy in 1; recurrent 
aseptic meningitis in 1; and aseptic meningitis, oral can-
didiasis, and bilateral pneumococcal pneumonia, in 1. 
Repeat lymph node biopsies were done on patients 
whose lymph nodes continued to enlarge after the initial 
biopsy or who developed additional symptoms. Six pa-
tients showed the identical lymph node pattern on repeat 
biopsy: explosive follicular hyperplasia in five patients 
and follicular involution in one patient. Two patients 
with explosive follicular hyperplasia were found to have 
follicular involution on subsequent biopsy, and another 
patient with follicular hyperplasia had a mixed pattern of 
follicular hyperplasia and follicular involution in the 
same lymph node. 
Malignant lymphomas developed in seven patients and 
included Burkitt's lymphoma involving lymph nodes and 
bone marrow in one patient; immunoblastic sarcoma 
with lymph node involvement in one patient, spinal cord 
compression in one patient, and a calf mass in one pa-
tient; polymorphic lymphoma with lymph node involve-
ment in one patient and multiple subcutaneous nodules in 
one patient; and mixed cellular (large cell and poorly 
differentiated) lymphoma that presented as multiple pul-
monary nodules in one patient. Central nervous system 
involvement occurred in four patients. 
Forty-two patients had the immunologic studies re-
peated three or more times. The responses to the mito-
gens and specific antigens showed significant improve-
ment in four patients and progressive decline in ten pa-
tients; no patients from the latter group have developed a 
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life-threatening opportunistic infection or lymphoma. 
The response to the mitogens and specific antigens in the 
remaining patients was unchanged. 
A subset of patients was found who had markedly de-
pressed responses to phytohemagglutinin and pokeweed 
mitogen and negative responses to C. albicans, E. coli, 
and S. aureus. Of 17 patients who met this criterion, 12 
have subsequently developed opportunistic infections or 
lymphomas. These abnormalities were present for 3 to 13 
months before diagnosis, which suggests that the lym-
phoproliferative assays may be useful in identifying a sub-
set of patients who are at increased risk for developing 
opportunistic infections and lymphomas. 
The present data do not allow us to make any correla-
tions about histologic features of lymph nodes or HLA 
phenotypes and clinical outcome. However, it is of inter-
est that the two patients who developed Kaposi's sarco-
ma were both positive for the HLA-DR5 antigen and 
negative for HLA-DR3. 
Discussion 
Generalized persistent lymphadenopathy has recently 
been described in homosexual men (8) . Our data indicate 
that generalized lymphadenopathy is associated with sig-
nificant immunologic abnormalities. In addition, 17% of 
patients followed prospectively developed a life-threaten-
ing opportunistic infection, malignant lymphoma, or Ka-
posi's sarcoma. Comparison of these patients for age, fre-
quency of sexual contacts, and history of sexually trans-
mitted diseases with patients who presented with Kapo-
si's sarcoma (5, 20) suggests that these patients are an 
interrelated population with similar risk factors—sexual 
promiscuity and frequent use of recreational drugs. The 
known exposure of these patients to persons who subse-
quently developed Kaposi's sarcoma, opportunistic infec-
tions, malignant lymphomas, or generalized lymphadeno-
pathy strongly supports the hypothesis that this syn-
drome is, in part, caused by a specific infectious agent 
(21). 
All patients showed abnormal responses in one or 
more of the cell-mediated studies. Negative cytotoxicity 
towards the target cell K562 was found in 4 8 % of pa-
tients. Depressed natural killer cell activity has been re-
ported to occur only in patients with certain primary im-
munodeficiency diseases or malignancies (22). Interferon 
has been shown to augment natural killer cell activity 
both by recruitment of new effector cells and by increased 
activation of the lytic process (23). The inability of al-
pha-interferon to augment this activity in our study indi-
cates that both mature and precursor natural killer cells 
are depleted or functionally suppressed. Individual pa-
tients showed varying degrees of impaired response to 
lymphocyte activation by mitogens. The greater depres-
sion in lymphocyte response to the microbial activators 
suggests that these tests may be a sensitive indicator for 
generalized immunosuppression in these patients. The 
immunologic studies also show that patients have pro-
found loss of T-cell function as seen in lymphoprolifera-
tive assays. 
As reported for patients with Kaposi's sarcoma (5, 24, 
25), there was a higher frequency of the HLA-DR5 phe-
notype in patients with generalized lymphadenopathy 
from the New York City area than would be expected in 
the general population. However, patients with Kaposi's 
sarcoma were found to have a low frequency of HLA-
DR3 (5, 24). It will be of interest to ascertain whether 
the HLA-DR3 antigen offers patients with generalized 
lymphadenopathy protection against the development of 
Kaposi's sarcoma and whether HLA-DR5 infers in-
creased risk, at least in some ethnic subgroups of whites, 
as previously suggested (24). The two patients in this 
study who developed Kaposi's sarcoma were both posi-
tive for the HLA-DR5 antigen and negative for HLA-
DR3 . These findings suggest that HLA-DR5 is a marker 
in patients who may be more susceptible to some compli-
cations of acquired immunodeficiency. Additional longi-
tudinal studies are necessary to ascertain the role of ge-
netic factors in the development of infectious and malig-
nant complications. 
Histologically, the hyperplastic lymph nodes were clas-
sified into three patterns: explosive follicular hyperplasia, 
follicular involution, and a mixed pattern of follicular 
hyperplasia and follicular involution in the same lymph 
node. Results of morphologic studies suggest dynamic 
histopathologic change. However, none of these patterns 
is diagnostic for acquired immunodeficiency. Follicular 
hyperplasia is seen in various situations, but the hyper-
plasia seen in homosexual men with generalized lympha-
denopathy is more reminiscent of the early stage of infec-
tious mononucleosis (26, 27). This hyperplasia differs 
from other nonspecific reactive conditions in its extreme 
degree. Parafollicular hyperplasia with inactive or invo-
luted follicles is seen in the late stage of infectious mono-
nucleosis as well as in postvaccinal lymphadenitis, lym-
phadenopathy due to anticonvulsant drugs, and viral 
lymphadenitis (26, 27). Taken together, the three histo-
logic patterns most resemble the changes seen in the vari-
ous stages of infectious mononucleosis (26, 27), X-linked 
lymphoproliferative disease (28, 29), and the lympho-
proliferative disorders found in renal transplant recipi-
ents (30, 31). Although an etiologic link has not been 
found, the levels of serum antibody to Epstein-Barr virus 
and the histological and clinical similarities between this 
syndrome and those mediated by Epstein-Barr virus sug-
gest the possibility of reactivation of latent viral infection. 
Our data strongly suggest that patients with general-
ized lymphadenopathy are part of the spectrum of a dis-
order manifested by acquired immunodeficiency, autoim-
mune phenomena (32), opportunistic infections (1-4), 
Kaposi's sarcoma (5) , and, in some cases, malignant 
lymphomas (6, 7) . This conclusion is supported by simi-
lar immunologic abnormalities (33, 34) and the high fre-
quency of opportunistic infections and malignancies that 
subsequently developed in patients with generalized lym-
phadenopathy. Recognition of persistent lymphadenopa-
thy in homosexual men is important, because it indicates 
an underlying immune dysfunction that may be augment-
ed by immunosuppressive treatment and possibly pre-
cedes opportunistic infections or malignant disorders. Al-
though no laboratory or immunologic assay is diagnostic 
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for this syndrome, the immunologic studies used here ap-
pear to identify patients with an immune dysfunction and 
may be useful prognostically. Whether the underlying 
immunodeficiency in these patients is reversible remains 
to be ascertained. Determining whether life-style factors 
contribute to and maintain the immunodeficiency will be 
particularly important. The natural course of this disor-
der is being explored in further longitudinal studies. 
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